Recently, DeHeng Hong Kong and Beijing offices assisted Hong Kong Pharma Digital Technology Holdings Limited to complete the listing on Nasdaq.

Recently, the first-instance verdict was announced in a financial crime case involving over RMB 100 billion represented by DeHeng lawyers. The court adopted some of the defense opinions presented by DeHeng, resulting in a se

On October 31, 2024, Beijing Biostar Biopharmaceuticals Co., Ltd. (stock code: 02563.HK) completed its initial public offering (IPO) of H-shares and was listed on the Main Board of the Hong Kong Stock Exchange.

On October 25, 2024, Anhui Jinpeng Flavors & Fragrances Co., Ltd. was listed on the National Equities Exchange and Quotations (NEEQ) system, with stock code 874648.

Recently, DeHeng assisted ZhongZhou Water Holding Co., Ltd. in obtaining the non-objection letter from the Shanghai Stock Exchange for its application to privately issue corporate bonds of no more than RMB 1 billion, with th

Recently, a large central enterprise completed an equity exit transaction with a local state-owned enterprise, receiving full investment proceeds and returns.